Skin micro-injector
Bold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments.
Projectdetails
Introduction
Needle-based injections are very common in modern medicine, notably in ongoing vaccination efforts worldwide. However, needle phobia and infection risks affect patient compliance with medical treatments, while millions of used needles contaminate the environment.
Challenges in Injection Methods
Lastly, the effectiveness of certain drugs increases when injected intradermally, but targeting the dermis is challenging. Thus, new minimal-invasive procedures are needed.
Jet Injectors Overview
Jet injectors are needle-free medical devices that pressurize thin liquid filaments to penetrate the skin. Jet injections have been effective in subcutaneous and intramuscular delivery, ex vivo, and in vivo.
Limitations of Current Jet Injection Methods
However, the expected needle-free revolution for medical treatments has neither been fulfilled nor widely commercialized due to factors such as:
- Bruising, a painful consequence of delivering large volumes in a single location.
- When using wrong energy settings, or misalignment with respect to the skin, the injected liquid can perfuse other layers.
- The rejected liquid splashes back, leading to incorrect dose delivery, risks of cross-contamination of the injector parts, or splash-back on the caregiver.
- Commercial jet injection methods, such as springs or compressed gas, are noisy which can distress the patient.
The Bold-Jet Solution
Hence, there is a need to develop a new way to deliver smaller doses with maximum accuracy in targeting specific skin layers. Bold-Jet is aimed at revolutionizing the experience of people who receive or perform frequent injections by developing, for the first time, a needle-free device using microjets that is safer, minimally invasive, and eco-friendly.
Benefits of Bold-Jet
By avoiding the use of needles, we can increase adherence to treatments by patients with fear of sharps and expand clinical routes for existing drugs and treatments.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-6-2022 |
Einddatum | 30-11-2023 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITEIT TWENTEpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Integrated needle-free injection and sensing using opto-microfluidicsiSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes. | EIC Transition | € 2.499.999 | 2024 | Details |
AmbiJet: the world’s first and only highly effective plasma-based solution for Europe’s 16 Million periimplantitis patients urgently needing help to avoid losing their dental implantAmbiJet is a groundbreaking plasma-based technology that effectively eliminates bacteria on dental implants, preventing reinfection and promoting better oral and overall health. | EIC Accelerator | € 1.389.062 | 2022 | Details |
Intravitreal InjectorDe IDE Group ontwikkelt een gebruiksvriendelijke intravitreal injector voor maculadegeneratie, waardoor de behandeling eenvoudiger, minder intimiderend en kosteneffectiever wordt. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
Dermaal microinjectie systeem met holle micronaalden voor oa vaccinatiesDit project onderzoekt de haalbaarheid van een pijnloos micro-injectiesysteem voor nauwkeurige medicatietoediening, met potentieel voor kankervaccinaties en verbeterde vaccinatiecapaciteit. | MIT Haalbaarheid | € 20.000 | 2021 | Details |
Integrated needle-free injection and sensing using opto-microfluidics
iSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes.
AmbiJet: the world’s first and only highly effective plasma-based solution for Europe’s 16 Million periimplantitis patients urgently needing help to avoid losing their dental implant
AmbiJet is a groundbreaking plasma-based technology that effectively eliminates bacteria on dental implants, preventing reinfection and promoting better oral and overall health.
Intravitreal Injector
De IDE Group ontwikkelt een gebruiksvriendelijke intravitreal injector voor maculadegeneratie, waardoor de behandeling eenvoudiger, minder intimiderend en kosteneffectiever wordt.
Dermaal microinjectie systeem met holle micronaalden voor oa vaccinaties
Dit project onderzoekt de haalbaarheid van een pijnloos micro-injectiesysteem voor nauwkeurige medicatietoediening, met potentieel voor kankervaccinaties en verbeterde vaccinatiecapaciteit.